Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

A human breast cancer cell divides as it moves through surrounding blood vessel cells in vitro.

Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.

A gene responsible for the free-moving, primitive nature of fetal cells is expressed in some breast cancer cells in mice and humans.

The University of Illinois professor studied the role of estrogen in breast cancer.

Researchers discover that a layer of human breast tissue is not one but two distinct cell types.  

The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.

Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.

In the largest study of its kind to date, researchers find more than 850 rare, heritable genetic alterations that can predispose humans to cancer.